Back

Mutant IDH impairs chromatin binding by PDGFB to promote chromosome instability

Curry, R. N.; McDonald, M. F.; He, P.; Lozzi, B.; Ko, Y.; O'Reilly, I.; Rosenbaum, A.; Kwon, W.; Fahim, L.; Marcus, J.; Powell, N.; Wang, S.; Ma, J.; Multani, A.; Choi, D.-J.; Sardar, D.; Mohila, C.; Lee, J.; Gallo, M.; Harmanci, A.; Harmanci, A. S.; Deneen, B.; Rao, G.

2025-02-25 cancer biology
10.1101/2025.02.20.639365 bioRxiv
Show abstract

Non-canonical roles for growth factors in the nucleus have been previously described, but their mechanism of action and biological roles remain enigmatic. Platelet-derived growth factor B (PDGFB) can drive formation of low-grade glioma and here we show that it localizes to the nucleus of human glioma cells where it binds chromatin to preserve genome stability and cell lineage. Failure of PDGFB to localize to the nucleus leads to chromosomal abnormalities, aberrant heterochromatin architecture and accelerated tumorigenesis. Furthermore, nuclear localization of PDGFB is reliant upon the expression levels and mutation status of isocitrate dehydrogenase (IDH). Unexpectedly, we identified macrophages as the predominant source of PDGFB in human, finding that immune-derived PDGFB can localize to the nucleus of glioma cells. Collectively, these studies show that immune derived PDGFB enters the nucleus of glioma cells to maintain genomic stability, while identifying a new mechanism by which IDH mutations promote gliomagenesis.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.